Gene Therapy, A Novel Therapeutic Tool for Neurological Disorders: Current Progress, Challenges and Future Prospective.

Current Gene Therapy
Ashif IqubalSyed Ehtaishamul Haque

Abstract

Neurological disorders are one of the major threat for health care system as they put enormous socioeconomic burden. All aged populations are susceptible to one or other neurological problems with symptoms of neuroinflammation, neurodegeneration and cognitive dysfunction. At present, available pharmacotherapeutics are insufficient to treat these diseased conditions and in most cases, they provide only palliative effect. It was also found that the molecular etiology of neurological disorders is directly linked with the alteration in genetic makeup, which can be inherited or triggered by the injury, environmental toxins and by some existing disease. Therefore, to take care of this situation, gene therapy has emerged as an advanced modality that claims to permanently cure the disease by deletion, silencing or edition of faulty genes and by insertion of healthier genes. In this modality, vectors (viral and non-viral) are used to deliver targeted gene into a specific region of the brain via various routes. At present, gene therapy has shown positive outcomes in complex neurological disorders, such as Parkinson's disease, Alzheimer's disease, Huntington disease, Multiple sclerosis, Amyotrophic lateral sclerosis and in lysosomal stora...Continue Reading

References

Oct 15, 1998·The New England Journal of Medicine·A E Lang, A M Lozano
Jun 26, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Grazia Paola NicchiaMaria Svelto
Jul 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frederick F LangW K Alfred Yung
Apr 13, 2004·Neuroreport·Mimoun AzzouzNicholas D Mazarakis
Oct 29, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Arto ImmonenSeppo Ylä-Herttuala
May 15, 2008·Brain : a Journal of Neurology·Francesco NoèAnnamaria Vezzani
May 20, 2008·Journal of Alzheimer's Disease : JAD·Claudia Schwab, Patrick L McGeer
Dec 23, 2008·Nature Biotechnology·Kevin D FoustBrian K Kaspar
Feb 26, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ryan L BoudreauBeverly L Davidson
Mar 12, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Tomomi KiyotaTsuneya Ikezu
Apr 16, 2009·Proceedings of the National Academy of Sciences of the United States of America·Beatrice ParadisoMichele Simonato
Apr 16, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sandra DuqueMartine Barkats
Aug 12, 2009·Neurobiology of Disease·N Joan AbbottDavid J Begley
Apr 7, 2010·Science Translational Medicine·Béchir JarrayaStéphane Palfi
Jul 8, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Shin-ichi MuramatsuImaharu Nakano
Aug 6, 2010·Brain Research Reviews·Filipa Lourenço CardosoMaria Alexandra Brito
Oct 22, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Diego PiedrahitaGloria Patricia Cardona-Gómez
Feb 1, 2011·Epilepsia·Panos TheofilasDetlev Boison
Mar 2, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Eloise HudryBradley T Hyman
Mar 20, 2012·Human Gene Therapy·Gabriele MittermeyerKrystof S Bankiewicz
Mar 20, 2012·Current Gene Therapy·Jean-Marc Humbert, Franck Halary
Apr 21, 2012·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Jonathan YunMaciej S Lesniak
Nov 14, 2012·Science Translational Medicine·Robert C WykesDimitri M Kullmann
Apr 5, 2013·The New England Journal of Medicine·Michael D HurdKenneth M Langa
Apr 19, 2013·Blood·Federico Mingozzi, Katherine A High
Jul 25, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Luis QuintinoCecilia Lundberg
Mar 13, 2014·Nature Reviews. Neurology·Christopher A RossSarah J Tabrizi
Jul 23, 2014·Proceedings of the National Academy of Sciences of the United States of America·Wenhui HuKamel Khalili
Aug 28, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Casey A MaguireXandra O Breakefield
Aug 29, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Neil Aronin, Marian DiFiglia
Mar 5, 2015·Journal of Clinical and Diagnostic Research : JCDR·Murali Ramamoorth, Aparna Narvekar
Oct 13, 2015·Advanced Drug Delivery Reviews·Jung Soo SukLaura M Ensign
Jun 2, 2016·Expert Opinion on Drug Delivery·Rahul Dev JayantMadhavan Nair
Dec 17, 2016·Nature Reviews. Neurology·Moira A McMahon, Don W Cleveland
Jan 12, 2017·Human Gene Therapy·Paul N Valdmanis, Mark A Kay
Feb 6, 2017·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Chaitanya R JoshiAnuja Ghorpade

❮ Previous
Next ❯

Citations

Jan 17, 2021·Journal of Periodontal Research·Abdelahhad BarbourMichael Glogauer
Mar 27, 2021·Orphanet Journal of Rare Diseases·Edward H SchuchmanCalogera M Simonaro
Oct 16, 2020·Current Gene Therapy·Ghulam Md Ashraf, Md Sahab Uddin

❮ Previous
Next ❯

Related Concepts

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Related Papers

Current Opinion in Investigational Drugs
Kenneth Lundstrom
Cellular and Molecular Biology
F Meyer, M Finer
Recent Patents on DNA & Gene Sequences
Amit K GoyalSuresh P Vyas
© 2021 Meta ULC. All rights reserved